Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)

Nathan P. Wiederhold, Thomas F. Patterson, Sandra Rebholz, James Brennan, Thomas Patton, John Barrett, Connell W.C. Boal, Monika Ehrensberger, Ryan Boyle, Melanie T. Cushion

Producción científica: Comment/debaterevisión exhaustiva

Resumen

Volume 66, no. 8, e00521-22, 2022, https://doi.org/10.1128/aac.00521-22. James Brennan, Thomas Patton, and John Barrett were not included in the byline in the original article. The byline and affiliation line should appear as shown above.

Idioma originalEnglish (US)
PublicaciónAntimicrobial agents and chemotherapy
Volumen67
N.º2
DOI
EstadoPublished - feb 2023

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology

Huella

Profundice en los temas de investigación de 'Erratum: The antifungal and anti-pneumocystis activities of the novel compound A3IS (Mycosinate) (Antimicrobial Agents and Chemotherapy (2022) 66:8 (e00521-22) DOI: 10.1128/aac.00521-22)'. En conjunto forman una huella única.

Citar esto